Xinxing I. Wang
No. 1 Jianshe East Road
Zhengzhou, 450000, China
Zhengzhou, 450000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A New Perspective on Regenerative Medicine: Plant-Derived Extracellular Vesicles.
Journal: Biomolecules
Published: June 04, 2025
Resolving tumor microenvironment heterogeneity to forecast immunotherapy response in triple-negative breast cancer through multi-scale analysis.
Journal: Frontiers in oncology
Published: December 03, 2024
DNA methylation profiling deciphers three EMT subtypes with distinct prognoses and therapeutic vulnerabilities in breast cancer.
Journal: Journal of Cancer
Published: March 08, 2024
Application of Multidisciplinary Diagnosis and Treatment (MDT) clinical teaching model in the clinical teaching of some undergraduates of breast diseases in surgery.
Journal: BMC medical education
Published: March 06, 2024
Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer.
Journal: Frontiers in oncology
Published: July 20, 2023
RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 15, 2022
Response evaluation in HER2-positive mucinous breast carcinoma after neoadjuvant chemotherapy: Progressive disease clinically but complete response pathologically.
Journal: Asian journal of surgery
Published: April 29, 2022
Aesthetic reconstruction of a partial breast defect with a rhomboid flap following wide surgical excision of idiopathic granulomatous mastitis.
Journal: Asian journal of surgery
Published: April 06, 2022
Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics.
Journal: Frontiers in genetics
Published: June 07, 2021
Aberrant super-enhancer-driven oncogene ENC1 promotes the radio-resistance of breast carcinoma.
Journal: Cell death & disease
Published: March 12, 2021
miR-30d suppresses proliferation and invasiveness of pancreatic cancer by targeting the SOX4/PI3K-AKT axis and predicts poor outcome.
Journal: Cell death & disease
Published: November 29, 2020
Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis.
Journal: Molecular oncology
Published: July 29, 2020
Last Updated: 09/26/2026